Variant report
Variant | esv2574880 |
---|---|
Chromosome Location | chr6:11902568-11904153 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:11900471..11902675-chr6:11931742..11933826,2 | K562 | blood: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs6937349 | chr6:11902591-11902592 | Weak transcription Enhancers ZNF genes & repeats | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs539375603 | chr6:11902592-11902593 | Weak transcription Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
3 | rs185740404 | chr6:11902639-11902640 | Enhancers Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
4 | rs6909423 | chr6:11902649-11902650 | Enhancers Weak transcription ZNF genes & repeats | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs6937513 | chr6:11902681-11902682 | Enhancers Weak transcription ZNF genes & repeats | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs545202248 | chr6:11902682-11902683 | Enhancers Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
7 | rs537936278 | chr6:11902683-11902684 | Enhancers Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
8 | rs575475735 | chr6:11902698-11902699 | Enhancers Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
9 | rs565081926 | chr6:11902714-11902715 | Enhancers Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
10 | rs6910727 | chr6:11902727-11902728 | Enhancers Weak transcription ZNF genes & repeats | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs6915058 | chr6:11902750-11902751 | Enhancers Weak transcription ZNF genes & repeats | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs114131830 | chr6:11902765-11902766 | Enhancers Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
13 | rs6941984 | chr6:11902804-11902805 | Enhancers Weak transcription ZNF genes & repeats | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs560426008 | chr6:11902852-11902853 | Enhancers Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
15 | rs190401278 | chr6:11903031-11903032 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs10701262 | chr6:11903084-11903085 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs372472684 | chr6:11903085-11903086 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs57429851 | chr6:11903086-11903087 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs200161674 | chr6:11903088-11903089 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs549201742 | chr6:11903098-11903099 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs566206506 | chr6:11903120-11903121 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs386697162 | chr6:11903125-11903126 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs73721880 | chr6:11903126-11903127 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs551663388 | chr6:11903135-11903136 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs112125879 | chr6:11903174-11903175 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 20164920 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Breast cancer | 21858162 | CNVD |
Lung cancer | 18438408 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Gastric cancer | 16891809 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 22495311 | CNVD |
Autism | 21448237 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 18172304 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Breast cancer | 22844521 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Ovarian cancer | 22844521 | CNVD |
Prostate cancer | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21552322 | CNVD |
Immune disease | 21076436 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Systemic lupus erythematosus | 17953491 | CNVD |
Recurrent Infections | 22737222 | CNVD |
Systemic lupus erythematosus | 21904924 | CNVD |
Ependymoma | 19289631 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Gestational infection | 22844521 | CNVD |
Head circumference | 22844521 | CNVD |
Infertility | 22844521 | CNVD |
Recurrent birth weight diabetes | 22844521 | CNVD |
Obesity | 22844521 | CNVD |
Recurrent pregnancy loss | 22844521 | CNVD |
Intellectual disability | 21811512 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Nasopharyngeal cancer | 22815911 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Cancer | 21183584 | CNVD |
Acute myeloid leukemia | 18000384 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21364760 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Bladder cancer | 21909424 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:11901400-11903000 | ZNF genes & repeats | K562 | blood |
2 | chr6:11901600-11902600 | Weak transcription | H1 Cell Line | embryonic stem cell |
3 | chr6:11901800-11903200 | Enhancers | Primary T cells from cord blood | blood |
4 | chr6:11902000-11902800 | Enhancers | Primary T helper cells PMA-I stimulated | -- |
5 | chr6:11902000-11903200 | Enhancers | Primary T helper naive cells fromperipheralblood | blood |
6 | chr6:11902200-11902600 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
7 | chr6:11902200-11902600 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
8 | chr6:11902200-11903000 | Weak transcription | Primary T regulatory cells fromperipheralblood | blood |
9 | chr6:11902400-11903000 | Enhancers | Primary T killer naive cells fromperipheralblood | blood |
10 | chr6:11902600-11903000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
11 | chr6:11902600-11903000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
12 | chr6:11902800-11903000 | Enhancers | H1 Cell Line | embryonic stem cell |
13 | chr6:11903000-11903200 | Enhancers | Primary T regulatory cells fromperipheralblood | blood |